Skip to content
10-K

Annual Report

ALIMERA SCIENCES, INC.

0001267602-24-000019

← back to feed
Filed
Mar 8, 2024 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 6, 2024 52.35M sh
Shares Diluted FY 2023 · Dec 31, 2023 25.56M sh
Shares Diluted FY 2023 · Dec 31, 2022 7M sh
Stock Repurchased FY 2023 · Dec 31, 2023 $314K
Capex FY 2023 · Dec 31, 2023 $260K
Capex FY 2023 · Dec 31, 2022 $255K
Operating Cash Flow FY 2023 · Dec 31, 2023 −$14.26M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$9.98M
Cash And Equivalents FY 2023 · Dec 31, 2023 $12.06M
Cash And Equivalents FY 2023 · Dec 31, 2022 $5.27M
Stockholders Equity FY 2023 · Dec 31, 2023 $46.17M
Stockholders Equity FY 2023 · Dec 31, 2022 −$20.81M
Stockholders Equity FY 2023 · Dec 31, 2021 −$2.61M
Current Liabilities FY 2023 · Dec 31, 2023 $21.91M
Current Liabilities FY 2023 · Dec 31, 2022 $39.73M
Total Liabilities FY 2023 · Dec 31, 2023 $107.35M
Total Liabilities FY 2023 · Dec 31, 2022 $63.41M
Current Assets FY 2023 · Dec 31, 2023 $52.42M
Current Assets FY 2023 · Dec 31, 2022 $29.41M
Total Assets FY 2023 · Dec 31, 2023 $153.52M
Total Assets FY 2023 · Dec 31, 2022 $42.6M
Eps Diluted FY 2023 · Dec 31, 2023 −$0.84
Eps Diluted FY 2023 · Dec 31, 2022 −$2.59
Eps Basic FY 2023 · Dec 31, 2023 −$0.84
Eps Basic FY 2023 · Dec 31, 2022 −$2.59
Sga Expense FY 2023 · Dec 31, 2023 $18.53M
Sga Expense FY 2023 · Dec 31, 2022 $12.87M
Rd Expense FY 2023 · Dec 31, 2023 $16.63M
Rd Expense FY 2023 · Dec 31, 2022 $16.23M
Net Income FY 2023 · Dec 31, 2023 −$20.13M
Net Income FY 2023 · Dec 31, 2022 −$18.11M
Operating Income FY 2023 · Dec 31, 2023 −$1.93M
Operating Income FY 2023 · Dec 31, 2022 −$11.64M
Gross Profit FY 2023 · Dec 31, 2023 $69.92M
Gross Profit FY 2023 · Dec 31, 2022 $46.15M
Revenue FY 2023 · Dec 31, 2023 $80.75M
Revenue FY 2023 · Dec 31, 2022 $54.13M